BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2309006)

  • 1. K(+)-channel activators in vascular smooth muscle.
    Cox RH
    Prog Clin Biol Res; 1990; 334():171-85. PubMed ID: 2309006
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative effects of the K+ channel openers, pinacidil and cromakalim on vascular tone: sensitivity to glyburide and calcium.
    Triggle CR; Li YQ; Wyse DG
    Proc West Pharmacol Soc; 1992; 35():97-102. PubMed ID: 1502246
    [No Abstract]   [Full Text] [Related]  

  • 3. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
    Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
    J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of Ki1769, a novel vasodilator, in isolated rat aorta.
    Kashiwabara T; Nakajima T; Kasai H; Nakajima S; Izawa T; Ogawa N
    Arch Int Pharmacodyn Ther; 1994; 327(2):175-83. PubMed ID: 7979826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of BRL 38227 on K-currents in rat portal vein.
    Edwards G; Noack T; Deitmer P; Weston AH
    Jpn J Pharmacol; 1992; 58 Suppl 2():336P. PubMed ID: 1507585
    [No Abstract]   [Full Text] [Related]  

  • 6. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tedisamil (KC 8857) differentially inhibits the 86Rb+ efflux-stimulating and vasorelaxant properties of cromakalim.
    Bray K; Quast U
    Eur J Pharmacol; 1991 Jul; 200(1):163-5. PubMed ID: 1769368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of rubidium on responses to potassium channel openers in rat isolated aorta.
    Greenwood IA; Weston AH
    Br J Pharmacol; 1993 Aug; 109(4):925-32. PubMed ID: 8401946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of KC-399, a newly synthesized potassium channel opener, on mechanical activity and 86Rb efflux in rat aorta.
    Tamura K; Suzuki Y; Yoshida S; Nabata H
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):220-6. PubMed ID: 7511750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of putative K+ channel activator BRL-34915 on arterial contraction and 86Rb efflux.
    Cox RH
    J Pharmacol Exp Ther; 1990 Jan; 252(1):51-9. PubMed ID: 2299602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo comparison of two K+ channel openers, diazoxide and cromakalim, and their inhibition by glibenclamide.
    Quast U; Cook NS
    J Pharmacol Exp Ther; 1989 Jul; 250(1):261-71. PubMed ID: 2501478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Some degree of overlap exists between the K(+)-channels opened by cromakalim and those opened by minoxidil sulphate in rat isolated aorta.
    Bray K; Quast U
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):351-9. PubMed ID: 1961260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The individual enantiomers of cis-cromakalim possess K+ channel opening activity.
    Quast U; Villhauer EB
    Eur J Pharmacol; 1993 Apr; 245(2):165-71. PubMed ID: 8491256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of guinea-pig tracheal smooth muscle responsiveness by the potassium channel openers NIP-121 and cromakalim.
    Shikada K; Yamamoto A; Tanaka S
    Jpn J Pharmacol; 1992; 58 Suppl 2():334P. PubMed ID: 1507583
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of K+ channel blockers on the relaxant action of dihydralazine, cromakalim and nitroprusside in isolated rabbit femoral arteries.
    Thirstrup S; Nielsen-Kudsk JE
    Eur J Pharmacol; 1992 May; 215(2-3):177-83. PubMed ID: 1396985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cromakalim, RP49356, diazoxide, glibenclamide and galanin in rat portal vein.
    Longmore J; Newgreen DT; Weston AH
    Eur J Pharmacol; 1990 Nov; 190(1-2):75-84. PubMed ID: 1706274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Advance in pharmacology of potassium channels in cardiovascular system and their clinical use].
    Wu Y; Fang D
    Zhonghua Yi Xue Za Zhi; 1992 Mar; 72(3):180-3. PubMed ID: 1319810
    [No Abstract]   [Full Text] [Related]  

  • 18. K(+)-channel openers for relaxation of isolated penile erectile tissue from rabbit.
    Holmquist F; Andersson KE; Fovaeus M; Hedlund H
    J Urol; 1990 Jul; 144(1):146-51. PubMed ID: 2359166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ion channels of vascular smooth muscle and pharmacological effects of calcium antagonists and potassium channel openers].
    Kitamura K; Ogata R
    Fukuoka Igaku Zasshi; 1994 Nov; 85(11):309-13. PubMed ID: 7851831
    [No Abstract]   [Full Text] [Related]  

  • 20. 8-(Diethylamino)-octyl-3,4,5-trimethoxybenzoate inhibits cromakalim-induced 86Rb efflux from the rat aorta.
    Lodge NJ; Halaka NN
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1399-405. PubMed ID: 8510016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.